Ayar Labs
ConvictionContext
Fabless chiplet + light-source IP/product vendor: sells the TeraPHY optical I/O chiplet and SuperNova external laser as a co-packaged offering to CPU/GPU/AI-accelerator makers and system builders; manufactures via foundry partners (GlobalFoundries), monetizes through product sales, NRE/engineering engagements, and ecosystem integration (NVLink Fusion).
Revenue
not disclosedpre-volume; primarily eval/NRE-stage revenueRev growth
not disclosedGross margin
not disclosedOp margin
not disclosedassumed deeply negative; pre-production, heavy R&D burnCapex intensity
low-to-moderatefabless; foundry-outsourced wafer + advanced packaging, no owned fabValuation
~$3.75BSeries E post-money, Mar 2026Valuation trail
Series E, $500M raise (~$870M cumulative)3.8× since Dec 2024
2 marks · Dec 2024–Mar 2026
private — no public price
Priced round
Both points are priced primary rounds; valuation ~275% higher over ~15 months on AI-infra demand, not disclosed revenue.
The read
Where our coverage leans
Coverage leans bullish
Sign in free to read the bull & bear take — Pro unlocks the full dossier.
Members only
Full financial intelligence for Ayar Labs
Earnings, margins & COGS, the income-statement breakdown, SWOT, moats & dependencies, the supplier–customer ecosystem graph, top signals & trends, and the valuation range.
- Income statement & margin structure
- SWOT, moats & dependency map
- Supplier–customer ecosystem graph
- Signals, trends & valuation range
Not investment advice — analyst work product for a qualified professional.· intel vintage 2026-07· sign in (free) for the analyst summary; Pro unlocks full intelligence